Literature DB >> 2819898

Distribution, metabolism and function of dolichol and polyprenols.

J W Rip, C A Rupar, K Ravi, K K Carroll.   

Abstract

Polyisoprenoid alcohols consisting of 9 or more isoprene units are present in all living cells. They can be fully unsaturated (polyprenols) or alpha-saturated (dolichol). Dolichol forms may have additional saturation at or near the omega-end. Some species contain ony dolichol or only polyprenols while others have nearly equal amounts of both types. Some polyisoprenoid alcohols consist entirely of trans isoprene units but most, including dolichol, contain both trans and cis units. Considerable advances in lipid methodology have occurred since the first review of polyisoprenoid alcohols by Hemming in 1974. For example, direct analysis of both dolichol and Dol-P by HPLC has replaced earlier methods which were often both insensitive and inaccurate. The availability of radiolabeled dolichol and polyprenols has facilitated studies concerning the metabolism and distribution of these compounds. Those studies suggest that only a small portion of the dolichol present in cells is likely to be involved in glycosylation. Polyisoprenoid alcohols are usually present at a family of homologues where each differs in size by one isoprene unit. Little or no size related specificity has been observed for any reaction involving dolichol or polyisoprenol intermediates. The overall length of polyisoprenoid alcohols may, however, affect the manner in which these compounds influence the physical and biochemical properties of membranes. Studies on the biosynthetic pathway leading from cis, trans Pol-PP by phosphatase action. The formation of the dolichol backbone from a polyprenol requires the action of an additional enzyme, an alpha-saturase. This enzyme does not always act at the level of a single common substrate, since Pol-PP, Pol-P, and polyprenol all appear to be utilized as substrates. The major product of the de novo pathway differs among different species. Dol-P would appear to be the most energy efficient end-product since it can participate directly in glycoprotein formation. Most often, however, Dol-P is not the major product of metabolic labeling experiments. In some cases, dolichol is formed so that rephosphorylation is required to provide Dol-P for participation in glycoprotein formation. The kinase responsible for this phosphorylation appears to bypass the considerable stores of dolichol present in tissues (i.e. sea urchin eggs) in favor of dolichol derived directly from de novo synthesis. Although HMGR is a major regulatory component of the pathway leading to polyisoprenoid alcohols and cholesterol, control is most often not co-ordinated.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2819898     DOI: 10.1016/0163-7827(85)90008-6

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  30 in total

Review 1.  Posttranslational protein modification in Archaea.

Authors:  Jerry Eichler; Michael W W Adams
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

Review 2.  Targeting the formation of the cell wall core of M. tuberculosis.

Authors:  Clifton E Barry; Dean C Crick; Michael R McNeil
Journal:  Infect Disord Drug Targets       Date:  2007-06

3.  A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy.

Authors:  Christian Kranz; Christoph Jungeblut; Jonas Denecke; Anne Erlekotte; Christina Sohlbach; Volker Debus; Hans Gerd Kehl; Erik Harms; Anna Reith; Sonja Reichel; Helfried Grobe; Gerhard Hammersen; Ulrich Schwarzer; Thorsten Marquardt
Journal:  Am J Hum Genet       Date:  2007-01-31       Impact factor: 11.025

Review 4.  Statins and neuroprotection: basic pharmacology needed.

Authors:  W Gibson Wood; Walter E Mΰller; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2014-01-29       Impact factor: 5.590

5.  Nogo-B receptor is necessary for cellular dolichol biosynthesis and protein N-glycosylation.

Authors:  Kenneth D Harrison; Eon Joo Park; Ningguo Gao; Andrew Kuo; Jeffrey S Rush; Charles J Waechter; Mark A Lehrman; William C Sessa
Journal:  EMBO J       Date:  2011-05-13       Impact factor: 11.598

Review 6.  The biological role of dolichol.

Authors:  T Chojnacki; G Dallner
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

7.  Low-density lipoprotein as a transporter of dolichol intermediates in the mammalian circulation.

Authors:  J W Rip; M M Blais; L W Jiang
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

8.  Dolichol biosynthesis in human malignant cells.

Authors:  A Henry; P W Stacpoole; C M Allen
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

9.  Effect of dietary fat on rat liver microsomal and mitochondrial/lysosomal dolichol, phospholipid and cholesterol.

Authors:  A Jakobsson-Borin; O Tollbom; G Dallner
Journal:  Lipids       Date:  1991-11       Impact factor: 1.880

10.  Quantification of dolichol in the human lens with different types of cataracts.

Authors:  Devarshi Gajjar; Adam Jozwiak; Ewa Swiezewska; Bhagwat Alapure; Trilok Parmar; Kaid Johar; Abhay R Vasavada
Journal:  Mol Vis       Date:  2009-08-11       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.